Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure
PURPOSE:To assess whether late introduction of a specific COX-2 inhibitor (Meloxicam) can treat and/or prevent the progression of tumors in the stomach of rats submitted to duodenogastric reflux. METHODS: Seventy five male Wistar rats, weighing 150 grams, were submitted to the induction of duodenoga...
Main Authors: | Paulo Antônio Rodrigues, Luiz Eduardo Naresse, Maria Aparecida Marchesan Rodrigues, Shoiti Kobayasi |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
2013-06-01
|
Series: | Acta Cirúrgica Brasileira |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502013000600009 |
Similar Items
-
Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure
by: Paulo Antônio Rodrigues, et al.
Published: (2013-06-01) -
Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect?
by: Rosângela Lucinda Rocha Monteiro, et al.
Published: (2020-09-01) -
Influence of duodenogastric reflux in the gastric mucosa histological changes of rats infected with Helicobacter pylori
by: JOSÉ CARLOS RIBEIRO DE ARAUJO, et al. -
COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs
by: Evrim eGurpinar, et al.
Published: (2013-07-01) -
Chemoprevention of Gastric Cancer: Metformin
by: Young-Il Kim, et al.
Published: (2017-12-01)